VOYA Investment Management
FULC icon

VOYA Investment Management’s Fulcrum Therapeutics FULC Stock Holding History

VOYA Investment Management’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.2K Buy
12,345
+2,321
+23% +$14.1K ﹤0.01% 2461
2026
Q1 		$76.9K Buy
+10,024
New +$93K ﹤0.01% 2227
2025
Q3 		– Sell
-15,411
Closed -$106K – 2521
2025
Q2 		$106K Sell
15,411
-3,137
-17% -$16.8K ﹤0.01% 2481
2025
Q1 		$53.4K Sell
18,548
-1,340
-7% -$4.92K ﹤0.01% 2539
2024
Q4 		$93.5K Sell
19,888
-1,783
-8% -$6.58K ﹤0.01% 2591
2024
Q3 		$77.4K Buy
21,671
+517
+2% +$3.84K ﹤0.01% 2709
2024
Q2 		$131K Buy
+21,154
New +$160K ﹤0.01% 2600
2023
Q2 		– Sell
-43,286
Closed -$123K – 2953
2023
Q1 		$123K Buy
43,286
+8,415
+24% +$75.4K ﹤0.01% 2663
2022
Q4 		$254K Buy
34,871
+7,962
+30% +$51.9K ﹤0.01% 2439
2022
Q3 		$218K Buy
26,909
+13,496
+101% +$96.6K ﹤0.01% 2554
2022
Q2 		$66K Buy
13,413
+2,035
+18% +$19.9K ﹤0.01% 2703
2022
Q1 		$269K Buy
11,378
+1,297
+13% +$18.4K ﹤0.01% 2221
2021
Q4 		$178K Sell
10,081
-470
-4% -$9.31K ﹤0.01% 2550
2021
Q3 		$298K Buy
+10,551
New +$200K ﹤0.01% 2352

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VOYA Investment Management's FULC Position: Q2 2026 in Review

VOYA Investment Management increased its Fulcrum Therapeutics (FULC) stake by 23% in Q2 2026, buying an estimated $14.1K and bringing the position to 12,345 shares worth $45.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2461.

VOYA Investment Management first reported a position in FULC in Q3 2021 and has held it in 14 quarters since. The position peaked at $298K in Q3 2021. 155 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • VOYA Investment Management held 12,345 shares of Fulcrum Therapeutics worth $45.2K as of Q2 2026.
  • VOYA Investment Management bought 2,321 Fulcrum Therapeutics shares in Q2 2026, an estimated $14.1K.
  • Fulcrum Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2461 holding.
  • VOYA Investment Management first reported a position in Fulcrum Therapeutics in Q3 2021 and has held it in 14 quarters since.
  • VOYA Investment Management's Fulcrum Therapeutics position peaked at $298K in Q3 2021.
  • 155 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.